Nuvio

Nuvio

United StatesUnited States
•Seed•Founded 2022•Updated 2 months ago
HealthtechAI/MLIOTHardwareB2BB2CB2B2C6-10 employees
First-Time FounderFirst-Time FounderActively Raising

About

Predictive mobility intelligence for aging care. Nuvio captures every walk passively, continuously, visible to the care team through sensor-enabled mobility aids that provide 15+ clinically relevant metrics without requiring wearables or manual testing.

Traction & Metrics

Users & Clients

150

Users

4

Clients

Products

Nuvio One

Premium rollator walker features 20% faster sit-to-stand, 25% greater functional reach, and 90% user preference vs. comparator rollators. FDA registered Class 1 device with 60% gross margin at ~$500 ASP. Post-soft launch production with peak ~$50K/month run rate, now shifting to profitable unit economics with scaled production.

Click to read more

Nuvio Pro

Clinical analytics platform launching Q1 2027 that provides 15+ clinically relevant mobility metrics captured passively from Nuvio devices. Subscription-based intelligence layer ($1.2K-$3K per walker per year) offering continuous gait monitoring, decline prediction, risk scoring, and outcomes attribution for rehab and aging care providers. API-ready with 2.5 month device payback period.

Click to read more

Want to connect with this startup?

Sign up for FirstGlance to follow startups, save favorites, and connect with founders.

Sign up free